VANGUARD GROUP INC - IMPRIMIS PHARMACEUTICALS INC ownership

IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 26 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of IMPRIMIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$5,103,000
+151.3%
896,880
+22.8%
0.00%
Q3 2018$2,031,000
+29.8%
730,391
+2.7%
0.00%
Q2 2018$1,565,000
+30.9%
711,291
+4.7%
0.00%
Q1 2018$1,196,000
+6.0%
679,366
+2.4%
0.00%
Q4 2017$1,128,000
+39.6%
663,570
+32.2%
0.00%
Q3 2017$808,000
-44.0%
501,867
+11.2%
0.00%
Q2 2017$1,444,000
+36.7%
451,226
+78.2%
0.00%
Q1 2017$1,056,000
+106.2%
253,158
+23.6%
0.00%
Q4 2016$512,000
-27.4%
204,872
+10.8%
0.00%
Q3 2016$705,000
+11.2%
184,984
+9.7%
0.00%
Q2 2016$634,000
-3.6%
168,584
+1.7%
0.00%
Q1 2016$658,000
-39.7%
165,753
+5.3%
0.00%
Q4 2015$1,091,000
-99.2%
157,366
-96.4%
0.00%
-100.0%
Q3 2015$129,733,000
+17647.3%
4,377,929
+4766.2%
0.01%
Q2 2015$731,000
+4.6%
89,966
+2.6%
0.00%
Q1 2015$699,000
+6.2%
87,6700.0%0.00%
Q4 2014$658,000
+1.1%
87,6700.0%0.00%
Q3 2014$651,000
+8.5%
87,670
+1.5%
0.00%
Q2 2014$600,000
+14.9%
86,373
+9.7%
0.00%
Q1 2014$522,000
+147.4%
78,704
+24.7%
0.00%
Q4 2013$211,000
-29.2%
63,1000.0%0.00%
Q3 2013$298,000
-44.3%
63,1000.0%0.00%
Q2 2013$535,00063,1000.00%
Other shareholders
IMPRIMIS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,722,000$9,798,0003.66%
Diametric Capital, LP 252,160$1,453,0001.12%
Birchview Capital, LP 180,000$1,024,0000.97%
EAM Global Investors LLC 206,445$1,175,0000.64%
EAM Investors, LLC 301,415$1,715,0000.47%
BARD ASSOCIATES INC 51,550$293,0000.17%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 85,569$487,0000.11%
ARDSLEY ADVISORY PARTNERS LP 75,000$427,0000.11%
PRELUDE CAPITAL MANAGEMENT, LLC 112,859$642,0000.04%
ELLINGTON MANAGEMENT GROUP LLC 16,500$94,0000.03%
View complete list of IMPRIMIS PHARMACEUTICALS INC shareholders